Intrinsic Value of S&P & Nasdaq Contact Us

Omeros Corporation OMER NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$40.00
+237.8%

Omeros Corporation (OMER) has a consensus analyst rating of Buy, based on 19 analysts covering the stock. Of those, 11 recommend buying, 6 recommend holding, and 2 recommend selling.

The analyst consensus price target for OMER is $40.00, representing a +237.8% upside from the current price of $11.84. Price targets range from a low of $40.00 to a high of $40.00.

Analyst Consensus — OMER

Buy
Strong Buy
1
Buy
10
Hold
6
Sell
2
Strong Sell
0
19 analysts
Price Targets
Consensus$40.00
High$40.00
Low$40.00
Median$40.00
Last Month Avg-
Last Quarter Avg$40.00
Last Year Avg$23.00
All-Time Count4
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message